N-acetylcysteine for liver failure not caused by acetaminophen
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether the drug N-acetylcysteine (NAC) can help people with sudden liver failure that is not caused by acetaminophen (like Tylenol). If you qualify, you may receive NAC, which might help your liver recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have sudden liver failure that was NOT caused by taking too much acetaminophen (like Tylenol).
- The cause of your liver failure should be from viral hepatitis (A, B, or E), a drug (other than acetaminophen), or an unknown cause.
- You must NOT have already received N-acetylcysteine (NAC) for this episode of liver failure.
- You cannot have a history of chronic liver disease or cirrhosis, or have had a liver transplant.
- You cannot be pregnant, and you must not have severe heart, kidney, brain, or infectious diseases, or be allergic to NAC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at children with sudden severe liver injury. It tests treatments for acute liver failure to understand how to help them recover.
This study looks at people with acute liver failure—a serious condition where the liver suddenly stops working—to understand what causes it and predict how patients will do. Researchers collect information about patients' health to identify patterns that might help doctors treat future patients better.
This study tests whether adding N-acetylcysteine to standard treatment helps people with severe alcoholic hepatitis. It may improve liver outcomes, especially for those with a high Maddrey score.
This Phase 2 trial studies whether TYNADOTE® can treat people who have taken a harmful acetaminophen (Tylenol) overdose while checking safety. It may be considered if your overdose is high enough to put you at risk for liver injury and you can follow the treatment and follow-up visits.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This trial tests whether an oral medicine called N-acetylcysteine (NAC) is safe and well-tolerated in infants with biliary atresia. It looks for participants who are 4–9 months old, can eat and take medicines by mouth, and will stay in the hospital for at least 4 days.
Hear when a new Acute Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.